FREE SHIPPING ON ORDERS OVER $150

semaglutide aha Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation Effects of Semaglutide on Stroke

$25.88

Quantity
- +
Description

doi: 10.3389/fpubh.2022.996179 10

semaglutide aha Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation Effects of Semaglutide on Stroke

For Phase 1, that is 0.25mg

semaglutide aha Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation Effects of Semaglutide on Stroke

Role of funding source The funder of the study provided study drugs and was involved in study design, data collection, data analyses, data interpretation and writing of the report

semaglutide aha Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation Effects of Semaglutide on Stroke

Eat a balanced diet

semaglutide aha Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation Effects of Semaglutide on Stroke

You may also like

recommand products